Treffer 1 - 2 von 2 für Suche 'Halbe, Sophia', Suchdauer: 0,61s Treffer weiter einschränken
  1. 1
    Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron

    Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron von Kreye, Jakob, Reincke, S. Momsen, Edelburg, Stefan, Jeworowski, Lara M., Kornau, Hans-Christian, Trimpert, Jakob, Hombach, Peter, Halbe, Sophia, Nölle, Volker, Meyer, Martin, Kattenbach, Stefanie, Sánchez-Sendin, Elisa, Schmidt, Marie L., Schwarz, Tatjana, Rose, Ruben, Krumbholz, Andi, Merz, Sophie, Adler, Julia M., Eschke, Kathrin, Abdelgawad, Azza, Schmitz, Dietmar, Sander, Leif E., Janssen, Uwe, Corman, Victor M., Prüss, Harald

    Veröffentlicht in iScience

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron

    Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron von Kreye, Jakob, Reincke, S. Momsen, Edelburg, Stefan, Jeworowski, Lara M, Kornau, Hans-Christian, Trimpert, Jakob, Hombach, Peter, Halbe, Sophia, Nölle, Volker, Meyer, Martin, Kattenbach, Stefanie, Sánchez-Sendin, Elisa, Schmidt, Marie L, Schwarz, Tatjana, Rose, Ruben, Krumbholz, Andi, Merz, Sophie, Adler, Julia M, Eschke, Kathrin, Abdelgawad, Azza, Schmitz, Dietmar, Sander, Leif E, Janssen, Uwe, Corman, Victor M, Prüss, Harald

    Volltext bestellen
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: